Literature DB >> 8252681

Myocardial force-frequency defect in mitral regurgitation heart failure is reversed by forskolin.

L A Mulieri1, B J Leavitt, B J Martin, J R Haeberle, N R Alpert.   

Abstract

BACKGROUND: Postoperative ejection phase parameters and patient survival rates for mitral valve replacement surgery are considerably lower than for similar aortic valve surgery. While chordal transection probably is the major contributor to the lowered values, there is also evidence for decreased preoperative myocardial contractile reserve in mitral regurgitation patients. This study characterizes abnormalities in the force-frequency relation that may underlie impaired function of myocardium isolated from mitral regurgitation patients with New York Heart Association class II-III heart failure. METHODS AND
RESULTS: Left ventricular epicardial myocardium was obtained by surgical biopsy during mitral valve replacement surgery in patients with mitral regurgitation heart failure (left ventricular ejection fraction, 0.64 +/- 0.05) and during coronary artery bypass surgery in patients with normal ventricular function. The steady-state twitch tension versus frequency relation was measured in myocardial strip preparations (37 degree C, 12 to 228 min-1) in the absence and presence of forskolin. Relative to normal function, peak isometric twitch tension in mitral regurgitation is depressed by 50% (P < .02) and 74% (P < .003) at contraction frequencies of 60 min-1 and 168 min-1, respectively. The slope of the tension-frequency curve is blunted and its peak is shifted to a lower frequency (mitral regurgitation: 134 min-1; normal function: 173 min-1; P < .02). The myosin heavy chain concentration did not differ between mitral regurgitation and normal function strips (53 +/- 4 versus 54 +/- 4 nmol/g blotted wt). Forskolin (0.5 mumol/L) completely reversed the tension depression, blunting, and the lowered peak frequency in the mitral regurgitation preparations.
CONCLUSIONS: Preoperatively, myocardial tension generation in mitral regurgitation patients is severely depressed, and the force-frequency curve is blunted and has a negative slope in the exercise range of heart rates. The reversal of these defects by forskolin suggests that abnormal excitation-contraction coupling may underlie the decreased contractile reserve in mitral regurgitation patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8252681     DOI: 10.1161/01.cir.88.6.2700

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

1.  Force-frequency relationship as a predictor of long-term prognosis in patients with heart diseases.

Authors:  Komei Tanaka; Makoto Kodama; Masahiro Ito; Makoto Hoyano; Wataru Mitsuma; Mahmoud M Ramadan; Takeshi Kashimura; Satoru Hirono; Yuji Okura; Kiminori Kato; Haruo Hanawa; Yoshifusa Aizawa
Journal:  Heart Vessels       Date:  2010-10-27       Impact factor: 2.037

2.  Increased oxidative stress and cardiomyocyte myofibrillar degeneration in patients with chronic isolated mitral regurgitation and ejection fraction >60%.

Authors:  Mustafa I Ahmed; James D Gladden; Silvio H Litovsky; Steven G Lloyd; Himanshu Gupta; Seidu Inusah; Thomas Denney; Pamela Powell; David C McGiffin; Louis J Dell'Italia
Journal:  J Am Coll Cardiol       Date:  2010-02-16       Impact factor: 24.094

Review 3.  Functional consequences of sarcomeric protein abnormalities in failing myocardium.

Authors:  Martin M LeWinter
Journal:  Heart Fail Rev       Date:  2005-09       Impact factor: 4.214

Review 4.  Role of oxidative stress in disease progression in Stage B, a pre-cursor of heart failure.

Authors:  Arvind Bhimaraj; W H Wilson Tang
Journal:  Heart Fail Clin       Date:  2011-10-22       Impact factor: 3.179

Review 5.  Drug Therapy for Heart Valve Diseases.

Authors:  Jeffrey S Borer; Abhishek Sharma
Journal:  Circulation       Date:  2015-09-15       Impact factor: 29.690

6.  Sarcoplasmic reticulum Ca2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy.

Authors:  M Flesch; R H Schwinger; P Schnabel; F Schiffer; I van Gelder; U Bavendiek; M Südkamp; F Kuhn-Regnier; M Böhm
Journal:  J Mol Med (Berl)       Date:  1996-06       Impact factor: 4.599

7.  Increased sarcolipin expression and adrenergic drive in humans with preserved left ventricular ejection fraction and chronic isolated mitral regurgitation.

Authors:  Junying Zheng; Danielle M Yancey; Mustafa I Ahmed; Chih-Chang Wei; Pamela C Powell; Mayilvahanan Shanmugam; Himanshu Gupta; Steven G Lloyd; David C McGiffin; Chun G Schiros; Thomas S Denney; Gopal J Babu; Louis J Dell'Italia
Journal:  Circ Heart Fail       Date:  2013-12-02       Impact factor: 8.790

8.  Mitral regurgitation: has another magic bullet bitten the dust?

Authors:  Jeffrey S Borer
Journal:  Circ Heart Fail       Date:  2013-07       Impact factor: 8.790

Review 9.  Myocardial contractility in the echo lab: molecular, cellular and pathophysiological basis.

Authors:  Tonino Bombardini
Journal:  Cardiovasc Ultrasound       Date:  2005-09-08       Impact factor: 2.062

10.  Cardiac reflections and natural vibrations: force-frequency relation recording system in the stress echo lab.

Authors:  Tonino Bombardini; Vincenzo Gemignani; Elisabetta Bianchini; Lucia Venneri; Christina Petersen; Emilio Pasanisi; Lorenza Pratali; Mascia Pianelli; Francesco Faita; Massimo Giannoni; Eugenio Picano
Journal:  Cardiovasc Ultrasound       Date:  2007-11-22       Impact factor: 2.062

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.